Vylor Inc. Q3 FY2026 earnings call

• Separation and Standalone Status: Vylor successfully completed its separation from Corteva on October 1, 2026, operating as an independent public company. The transition was executed on time and under budget, allowing the firm to begin standalone operations from a position of financial strength.
• Strategic Focus on Licensing: A key operational highlight is the strategic shift in Brazil soybeans from branded seed sales to a licensing model. This transition reduces near-term reported volume but significantly improves margins, with licensing margins being approximately three times higher than traditional branded business margins. Vylor crossed into a net out-licensing position for the first time in seven years.
• Technology Pipeline Milestones: Management highlighted strong demand for corn germplasm and trait technology in North America, noting that licensing contracts nearly doubled from 2025 to 2026. Additionally, the company announced plans to launch its first hybrid wheat product in 2027 and enter the high-value triple-stack corn licensing market in North America, signaling expansion into new addressable markets.
• Operational Resilience: Despite adverse weather conditions including historic droughts in Europe and delayed monsoons in Asia Pacific, Vylor demonstrated resilience through disciplined execution on 'price for value' strategies and productivity actions. Royalty income is expected to increase by more than $100 million, supported by the Brazil licensing change and North American corn.

For the third quarter of 2026, Vylor reported net sales of $938 million, a decrease of 1% year-over-year (with organic sales down 3%). Operating EBITDA was a loss of $269 million, down 33% compared to the prior year. This decline was primarily driven by timing shifts in Brazil soybean licensing revenue and weather-related volume pressures. For the first nine months of 2026, net sales increased 4% to $8.5 billion, while operating EBITDA rose 8% to approximately $2.7 billion, achieving an operating EBITDA margin of 31.2%. The Americas segment drove margin expansion through licensing benefits and productivity, whereas the Rest of World segment faced margin contraction due to drought impacts in EMEA and Asia Pacific.

• Full Year 2026 Revenue: Reaffirmed expectation of approximately $10.4 billion in net sales, representing roughly 3% growth versus the prior year.
• Full Year 2026 EBITDA: Reaffirmed operating EBITDA target of approximately $2.8 billion, indicating about 10% growth.
• Margin Expansion: Targeted operating EBITDA margin of approximately 27%, reflecting a structural expansion of about 100 basis points.
• Earnings Per Share: Expected operating EPS of $2.25 to $2.35, with a midpoint representing approximately 5% growth.
• Long-Term Framework (2027-2029): Targets annual net sales growth of 3% to 4% and fairly ratable annual operating EBITDA growth of 7% to 8%. By 2029, the company targets an operating EBITDA margin of approximately 30% at the midpoint.

• Weather Volatility: Significant exposure to global weather patterns, including historic droughts in EMEA, delayed rainfall in Asia Pacific, and El Niño effects in Latin America, which impact planted acreage and volumes.
• Macroeconomic Pressures: Elevated freight, warehousing, and energy-related costs, along with higher SG&A expenses including legal fees and IT costs, pressure profitability.
• Brazilian Farmer Economics: Tight cash and credit conditions for Brazilian farmers due to high interest rates pose risks to demand, though mitigated by barter programs and the necessity of seed investment for yield.
• Regulatory Uncertainty: Delays in gene-editing regulatory approvals in China and varying implementation timelines for EU directives create uncertainty for future product launches.
• Supply Chain Constraints: Supply limitations for new technologies, such as triple-stack corn, may restrict the ability to meet strong licensee demand in the short term.

Q: Analyst asked if the $180 million net licensee fee guide implies conservative 3-year targets and if Conkesta drives H2 results. / A: CEO stated licensing is the largest near-term value opportunity, hitting royalty neutrality after 7 years. Conkesta trait penetration in Brazil exceeded 10%, and US corn licensing demand is strong but supply-limited. Judd O'Connor added that North American corn licensing nearly doubled YoY, with order books supporting 40-50% growth into 2027, validating the framework's conservatism.

Q: Analyst inquired about Brazilian Safrinha crop outlook despite El Niño and North American order book strength. / A: CEO noted extreme weather globally but emphasized early indications for Safrinha are positive due to timely soybean planting. Judd O’Connor confirmed summer crops went in well, setting up Safrinha; acres are flat but poised to expand. In North America, Brevant share is growing exponentially, and Pioneer gained share in Eastern/Western Corn Belts, though some was lost in the South due to dicamba pressure.

Q: Analyst questioned the composition of the $3 billion 2027 EBITDA placeholder regarding Brazil strategy changes and commodity prices. / A: CEO clarified no formal 2027 guide yet but views setup as constructive due to record grain/biofuel demand and below-average stocks. Expected rebound in Europe/APAC acres and stable US plantings support volume. CFO David Johnson added that ~$100 million in ratable licensing revenue will contribute, offset slightly by incremental licensing costs as corn supply ramps up, supporting the 7-8% EBITDA growth target.

Q: Analyst asked about the revenue recognition timing shift for triple-stack corn licensing compared to the Brazil soybean model. / A: CEO explained Qrome (triple-stack) is in ramp-up mode post-settlement, with significant impact expected in 2028-2029 rather than 2027 due to production constraints. CFO noted revenue timing depends on contract structures (upfront vs. per bag). Unlike Brazil’s distinct Q3-to-Q4 shift, corn licensing timing varies by contract but generally follows similar end-to-end processes for doubles and triples.

Q: Analyst asked about the competitive advantage of Vylor’s hybrid wheat technology and global rollout plans. / A: CEO highlighted Vylor’s proprietary Xpedite system as the only cost-effective method for commercial hybrid wheat production, offering up to 20% yield gains in dry conditions. Launch begins in the US in 2027 with global expansion to Asia, LatAm, and Europe. Goal is $500M revenue by 2035/$1B by 2040, establishing it as a third major franchise alongside corn and soybeans.